Clinical trial
Pediatric Epilepsy Study
NCT00050934 · Novartis Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00050934 |
|---|---|
| Title | Pediatric Epilepsy Study |
| Official title | A Multicenter, Rater-blind, Randomized, Age-stratified, Parallel-group Study Comparing Two Doses of Oxcarbazepine as Adjunctive Therapy in Pediatric Patients With Inadequately-controlled Partial Seizures. |
| Lead sponsor | Novartis Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Epilepsy, Epilepsies, Partial |
| Intervention type | Drug |
| Interventions | oxcarbazepine |
| Enrollment | 132 |
| Start date | Jun 1, 2002 |
| Primary completion | Jun 1, 2004 |
| Completion | Jun 1, 2004 |
| First posted | Jan 1, 2003 |
| Last update posted | Nov 23, 2011 |
| Countries | Brazil, Germany, Mexico, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: